AL

Alignment Healthcare, Inc.

ALHCHealthcareNASDAQ

Healthcare Plans

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.95B
+46.1% YoY
Net Income
-$724,000
+99.4% YoY
EBITDA
$45.3M
+158.5% YoY
Free Cash Flow
$188.6M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 26 MACD Positive CrossoverHistogram +0.1789, positive momentum
Aug 25 MACD Positive CrossoverHistogram +0.1189, positive momentum
About Alignment Healthcare, Inc.

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. With a market capitalization of $2.79B, it sits in mid-cap territory. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans.

Where ALHC stands vs its 150-day and 200-day moving averages

As of the August 26, 2026 close, ALHC finished 28.25% below its 150-day moving average ($18.94) and 28.44% below its 200-day moving average ($18.99). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ALHC overbought or oversold?

At the August 26, 2026 close, ALHC's RSI(14) was 49.2, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$2.79B
P/E (TTM)70.84
Fwd P/E17.89
EPS$0.19
Beta1.11
52W Change-17.7%
ROE20.0%
Analysis

Alignment Healthcare, Inc. holds $701.7M in cash against $330.5M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $188.6M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 20.0% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.43B (2022) to $3.95B (2025), reflecting a 175% increase over the period.

The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Alignment Healthcare, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms